Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Early Detection/Cancer Prevention

Centre hospitalier de l'Université de Montréal (CHUM)

$100,000.00

The impact of intrauterine device use on ovarian cancer risk

FY 2022-23

Summary
The introduction of oral contraceptives, or "the pill", has not only been a milestone in terms of birth control, but its use has important benefits to women's health. In particular, using the pill is known to reduce the risk of ovarian cancer, which is the most deadly of the cancers that occur only in women. The pill has led to the introduction of other methods of birth control, including new choices in intrauterine devices, or "IUDs". IUDs are now the recommended first choice of birth control methods for woman of all ages, and its use is increasing globally. However, this has led to reduced use of the pill. The findings from past studies do not give a clear idea of whether the use of IUDs is associated with ovarian cancer risk. Also, most past studies have not examined all the types of IUDs that are available today. We will conduct a large, population-based study using data from the United Kingdom on primary medical care, hospitalization, and cancer and death registrations to examine whether IUD use, when compared with use of the pill, affects the development of ovarian cancer. We will also examine whether there may be differences by type of IUD. Ovarian cancer is a cancer of critical importance to women's health, given its high fatality. This project will help in understanding if the increasing use of IUDs, with lower use of the pill, may have an impact on how many people get ovarian cancer. The results will also provide information that women may use when making choices in birth control methods.
Program
Project Grant - Priority Announcement: Early Detection/Cancer Prevention
Location
Quebec, Canada
Recipient Type
Not-for-profit organization or charity
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472511
Name
Koushik Anita
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Public, Community & Population Health
Projecttitle
The impact of intrauterine device use on ovarian cancer risk
Programtype2
Operating Grants
Orgnameinp2
Centre hospitalier de l'Université de Montréal (CHUM)
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Early Detection/Cancer Prevention
Keyworddelim
Contraception; Epidemiology; Intrauterine Devices; Ovarian Cancer; Pharmacoepidemiology; Women'S Health
Abstract
The introduction of oral contraceptives, or "the pill", has not only been a milestone in terms of birth control, but its use has important benefits to women's health. In particular, using the pill is known to reduce the risk of ovarian cancer, which is the most deadly of the cancers that occur only in women. The pill has led to the introduction of other methods of birth control, including new choices in intrauterine devices, or "IUDs". IUDs are now the recommended first choice of birth control methods for woman of all ages, and its use is increasing globally. However, this has led to reduced use of the pill. The findings from past studies do not give a clear idea of whether the use of IUDs is associated with ovarian cancer risk. Also, most past studies have not examined all the types of IUDs that are available today. We will conduct a large, population-based study using data from the United Kingdom on primary medical care, hospitalization, and cancer and death registrations to examine whether IUD use, when compared with use of the pill, affects the development of ovarian cancer. We will also examine whether there may be differences by type of IUD. Ovarian cancer is a cancer of critical importance to women's health, given its high fatality. This project will help in understanding if the increasing use of IUDs, with lower use of the pill, may have an impact on how many people get ovarian cancer. The results will also provide information that women may use when making choices in birth control methods.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Koushik, Anita; Azoulay, Laurent
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Centre hospitalier de l'Université de Montréal (CHUM)… | Canada Spends